Export Metadata
| Title |
|
|---|---|
| Contributor | Frank Stadler(author) |
| DOI | https://doi.org/10.11647/obp.0300.16 |
| Landing page | https://www.openbookpublishers.com/books/10.11647/obp.0300/chapters/10.11647/obp.0300.16 |
| License | https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright | Frank Stadler |
| Publisher | Open Book Publishers |
| Publication place | Cambridge, UK |
| Published on | 2022-07-20 |
| Long abstract | This chapter is concerned with the packaging of medicinal maggots for sale and transport. After fly eggs have been disinfected, incubated, and the microbial safety of eggs and maggots has been confirmed, medicinal maggots are counted and transferred to primary packaging for safe transit to the point of care. This primary packaging may then be further packaged within a cardboard box that forms the secondary packaging along with package inserts that specify vital product and use information. In addition, when medicinal maggots are transported over greater distances or under unfavourable climatic conditions, insulated transport packaging is essential. |
| Page range | pp. 349–362 |
| Language | English (Original) |
Contributors
Frank Stadler
(author)Frank Stadler is the owner and director of Similitude Pty Ltd and MedMagLabs. He is also the Centre Manager at the ARC Training Centre for the Facilitated Advancement of Australia's Bioactives (FAAB) and Adjunct Fellow at Applied BioSciences, Macquarie University. At Griffith University, Frank holds an Adjunct Research Fellow position with the School of Medicine and Dentistry. For the past eight years he has conducted world-first research on supply chain management for maggot therapy in compromised healthcare settings. Frank has held positions in research, research management, science communication, and project management. He has curated a natural history museum, owned an environmental education business, and managed a multi-million-dollar portfolio of research at the National Climate Change Adaptation Research Facility, Griffith University. Frank has extensive expertise in maggot therapy and its supply chain management, invertebrate biology, and laboratory rearing of invertebrates. He and his colleagues established MedMagLabs, a two-year research and development project funded by Creating Hope in Conflict: A Humanitarian Grand Challenge, to develop medicinal maggot production and maggot therapy solutions for conflict-affected isolated communities. This work has motivated Frank to transition MedMagLabs in 2021 from a university research lab into a for-purpose private enterprise under the governance of Similitude Pty Ltd.
References
- 1. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Annex 9 — Guidelines on Packaging for Pharmaceutical Products. WHO Technical Report Series, No. 902 — Thirty-sixth Report. 2002. https://apps.who.int/iris/bitstream/handle/10665/42424/WHO_TRS_902.pdf;sequence=1.
- 2. Stadler, F., Distribution Logistics, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 363–382. https://doi.org/10.11647/OBP.0300.17.(opens in new tab)
- 3. Sherman, R., Medicinal Maggot Application and Maggot Therapy Dressing Technology, in A Complete Guide to Maggot Therapy: Clinical Practice, Therapeutic Principles, Production, Distribution, and Ethics, F. Stadler (ed.). 2022, Cambridge: Open Book Publishers, pp. 79–96, https://doi.org/10.11647/OBP.0300.05.(opens in new tab)
- 4. TGA. Code of Practice for Tamper-evident Packaging of Therapeutic Goods. Version 2.0, May 2017. https://www.tga.gov.au/sites/default/files/code-practice-tamper-evident-packaging-therapeutic-goods.pdf.
- 5. Hollein, L., et al., Routine Quality Control of Medicines in Developing Countries: Analytical Challenges, Regulatory Infrastructures and the Prevalence of Counterfeit Medicines in Tanzania. TrAC Trends in Analytical Chemistry 2016. 76: pp. 60–70, https://doi.org/10.1016/j.trac.2015.11.009. (opens in new tab)
- 6. Rotunno, R., et al., Impact of Track and Trace Integration on Pharmaceutical Production Systems. International Journal of Engineering Business Management, 2014. 6, 25: pp. 1–11, https://doi.org/10.5772/58934. (opens in new tab)
- 7. GS1, GS1 General Specifications. The Foundational GS1 Standard that Defines How Identification Keys, Data Attributes and Barcodes Must Be Used in Business Applications. Release 17.0.1. 2017, GS1. https://gs1it.org/content/public/58/d7/58d73d56-ebc1-4372-b6f0-e5d7d0a5abcc/gs1_general_specifications_v17.pdf.
- 8. HDMA, HDMA Guidelines for Bar Coding in the Pharmaceutical Supply Chain. 2011.
- 9. Australian Red Cross Blood Service, The Australian Guidelines for the Labelling of Blood Components Using ISBT 128. 2020, Australian Red Cross Blood Service. https://www.lifeblood.com.au/sites/default/files/resource-library/2021-12/94.-ISBT128-Australian-Guidelines-V9-final-30032020.pdf.
- 10. Schapranow, M.-P., et al., Costs of Authentic Pharmaceuticals: Research on Qualitative and Quantitative Aspects of Enabling Anti-counterfeiting in RFID-aided Supply Chains. Personal and Ubiquitous Computing, 2012. 16(3): pp. 271–289, https://doi.org/10.1007/s00779-011-0390-4. (opens in new tab)
- 11. Taylor, N. Sproxil & Orange Fight for Anti-counterfeiting Market in Kenya. 2011. https://www.outsourcing-pharma.com/Article/2011/10/13/Sproxil-Orange-fight-for-anti-counterfeiting-market-in-Kenya.
- 12. Zadbuke, N., et al., Recent Trends and Future of Pharmaceutical Packaging Technology. Journal of Pharmacy & Bioallied Sciences, 2013. 5(2): pp. 98–110, https://doi.org/10.4103/0975-7406.111820. (opens in new tab)
- 13. MedMagLabs. Creating Hope in Conflict: A Humanitarian Grand Challenge. http://medmaglabs.com/creating-hope-in-conflict/.
- 14. Richards, C.S., B.W. Price, and M.H. Villet, Thermal Ecophysiology of Seven Carrion-feeding Blowflies in Southern Africa. Entomologia Experimentalis et Applicata, 2009. 131(1): pp. 11–19, https://doi.org/10.1111/j.1570-7458.2009.00824.x. (opens in new tab)
- 15. Baer, W.S., The Treatment of Chronic Osteomyelitis with the Maggot (Larva of the Blow Fly). The Journal of Bone and Joint Surgery. American Volume, 1931. 13: pp. 438–475, https://doi.org/10.1007/s11999-010-1416-3. (opens in new tab)
- 16. Sherman, R.A. and F.A. Wyle, Low-cost, Low-maintenance Rearing of Maggots in Hospitals, Clinics, and Schools. American Journal of Tropical Medicine and Hygiene, 1996. 54(1): pp. 38–41, https://doi.org/10.4269/ajtmh.1996.54.38. (opens in new tab)
- 17. Čičková, H., M. Kozánek, and P. Takáč, Growth and Survival of Blowfly Lucilia sericata Larvae under Simulated Wound Conditions: Implications for Maggot Debridement Therapy. Medical and Veterinary Entomology, 2015. 29(4): pp. 416–424, https://doi.org/10.1111/mve.12135. (opens in new tab)
- 18. BioMonde. Application Guide and Daily Care Plan. 2015. http://biomonde.com/attachments/article/7/BM197_EN_03_0115.pdf.
- 19. Lloyd, J., et al., Reducing the Loss of Vaccines from Accidental Freezing in the Cold Chain: The Experience of Continuous Temperature Monitoring in Tunisia. Vaccine, 2015. 33(7): pp. 902–907, https://doi.org/10.1016/j.vaccine.2014.10.080. (opens in new tab)
- 20. Webster, J., I.M. Croteau, and J.P. Acker, Evaluation Of The Canadian Blood Services Red Blood Cell Shipping Container. Canadian Journal of Medical Laboratory Science, 2008. 70(5): pp. 167–176.
- 21. Stadler, F. Supply Chain Management for Maggot Debridement Therapy in Compromised Healthcare Settings. 2018. Unpublished doctoral dissertation, Griffith University, Queensland, https://doi.org/10.25904/1912/3170.
- 22. Lippi, G., et al., Suitability of a Transport Box for Blood Sample Shipment over a Long Period. Clinical Biochemistry, 2011. 44(12): pp. 1028–1029, https://doi.org/10.1016/j.clinbiochem.2011.05.028. (opens in new tab)
- 23. Samant, Y., et al., Evaluation of the Cold-chain for Oral Polio Vaccine in a Rural District of India. Public Health Reports, 2007. 122(1): pp. 112–121, https://doi.org/10.1177/003335490712200116. (opens in new tab)
- 24. Obradovic, Z., et al., The Impact of War on Vaccine Preventable Diseases. Materia Socio-Medica, 2014. 26(6): pp. 382–384, https://doi.org/10.5455/msm.2014.26.382-384. (opens in new tab)
- 25. Rogie, B., Y. Berhane, and F. Bisrat, Assessment of Cold Chain Status for Immunization in Central Ethiopia. Ethiopian Medical Journal, 2013. 51 Suppl 1: pp. 21–29.
- 26. Yakum, M.N., et al., Vaccine Storage and Cold Chain Monitoring in the North West Region of Cameroon: A Cross Sectional Study. BMC Research Notes, 2015. 8, 145: pp. 1–7, https://doi.org/10.1186/s13104-015-1109-9.(opens in new tab)
- 27. Fernando, M., An Analysis of Clinical Risks in Vaccine Transportation. British Journal of Community Nursing, 2004. 9(10): pp. 411–415, https://dx.doi.org/10.12968/bjcn.2004.9.10.16111. (opens in new tab)
- 28. Mallik, S., et al., Assessing Cold Chain Status in a Metro City of India: An Intervention Study. African Health Sciences, 2011. 11(1): pp. 128–133 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092313/.
- 29. Turner, N., A. Laws, and L. Roberts, Assessing the Effectiveness of Cold Chain Management for Childhood Vaccines. Journal of Primary Health Care, 2011. 3(4): pp. 278–282.
- 30. Forcinio, H., Packaging Addresses Cold-Chain Requirements. Pharmaceutical Technology Europe, 2014. 26(10): p. 54.
- 31. Chen, S.-I., et al., Passive Cold Devices for Vaccine Supply Chains. Annals of Operations Research, 2015. 230(1): pp. 87–104, https://doi.org/10.1007/s10479-013-1502-5. (opens in new tab)
- 32. Hartman, L.R., Pharma Packs Sustain Temperatures and the Environment: Walmart Specialty Pharmacy’s Thermal-management Shippers Maintain Temperatures, Regardless of the Weather, Are Sustainable and Cut Shipping Costs by 50 percent, in Packaging Digest. 2008, UBM Canon LLC. p. 50.
- 33. Oke, I.A., Management of Immunization Solid Wastes in Kano State, Nigeria. Waste Management, 2008. 28(12): pp. 2512–2521, https://doi.org/10.1016/j.wasman.2007.11.008. (opens in new tab)
- 34. Patwary, M.A., W.T. O’Hare, and M.H. Sarker, An Illicit Economy: Scavenging and Recycling of Medical Waste. Journal of Environmental Management, 2011. 92(11): pp. 2900–2906, http://dx.doi.org/10.1016/j.jenvman.2011.06.051. (opens in new tab)
- 35. Sartaj, M. and R. Arabgol. Quantitative Assessment and Statistical Analysis of Medical Waste Generation in Developing Countries: A Case Study in Ifahan (Iran). Iranian Journal of Science and Technology-Transactions of Civil Engineering 38: C2, 409–420, 2014. http://ijstc.shirazu.ac.ir/pdf_2418_9216d0a563d024c0edad2e847dd29774.html.
- 36. Pelican. Credo — Reusable Passive Thermal Packaging. http://www.pelicanbiothermal.com/products/credo.
- 37. Mohan, A.M. Study: Reusable Pharma Packs ‘Greener’ than Single Use. 2013. https://www.healthcarepackaging.com/article/sustainability/reusability/study-reusable-pharma-packs-greener-single-use.
- 38. PATH. Temperature Monitoring Devices: An Overview. 2013. http://www.path.org/publications/files/TS_opt_handout_tmd_overview.pdf.
